Natera NTRA
NASDAQ NTRA
$366.36 +21.02 (+6.08%)
As of: Sep 17, 2026 · 3:59 PM EDT

Natera (NTRA) Cash from Investing Activities (2014 - 2026)

Natera's (NTRA) quarterly Cash from Investing Activities came in at -$63.4 million in Q2 2026, down 165.43% on a YoY basis from $96.9 million in Q2 2025, and down 97.37% quarter-over-quarter from -$32.1 million in Q1 2026.

Analysis

Natera (NTRA) Cash from Investing Activities (2014 - 2026) Analysis & Trends

Natera (NTRA) has reported Cash from Investing Activities for 13 consecutive years, with -$63.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Investing Activities fell 165.43% year-over-year to -$63.4 million; the trailing twelve-month figure through Jun 2026 stood at -$187.1 million (down 1913.6% YoY), and the FY2025 full-year result was -$132.2 million, down 196.07% from the prior year.
  • Cash from Investing Activities declined to -$63.4 million in Q2 2026 per NTRA's latest filing, from -$32.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $207.0 million in Q1 2022 and bottomed at -$71.6 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged $22.7 million across 5 years, with a median of $18.9 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities surged 771.17% in 2024, then slumped 543.93% in 2025.
  • Over 5 years, Cash from Investing Activities stood at $21.9 million in 2022, then climbed by 10.17% to $24.1 million in 2023, then plunged by 146.05% to -$11.1 million in 2024, then plunged by 543.93% to -$71.6 million in 2025, then advanced by 11.4% to -$63.4 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$63.4 million, -$32.1 million, and -$71.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn -63.43 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -134.00 Mn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -366.20 Mn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 101.47 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -11.09 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -122.19 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -43.30 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -4.05 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -43.48 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn -48.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -63.43 Mn
Mar 31, 2026 -32.14 Mn
Dec 31, 2025 -71.59 Mn
Sep 30, 2025 -19.91 Mn
Jun 30, 2025 -23.90 Mn
Mar 31, 2025 -16.82 Mn
Dec 31, 2024 -11.12 Mn
Sep 30, 2024 42.54 Mn
Jun 30, 2024 -32.05 Mn
Mar 31, 2024 138.26 Mn
Dec 31, 2023 24.15 Mn
Sep 30, 2023 81.29 Mn
Jun 30, 2023 47.19 Mn
Mar 31, 2023 15.87 Mn
Dec 31, 2022 21.92 Mn
Sep 30, 2022 66.60 Mn
Jun 30, 2022 34.79 Mn
Mar 31, 2022 207.03 Mn
Dec 31, 2021 79.50 Mn
Sep 30, 2021 -431.41 Mn